Skip to content
Screener

AdvanSix ASIX Caprolactam — Sales

Other product segments

Plant Nutrients
$131.44M-16.2%
Chemical Intermediates
$126.98M+18.3%
Nylon
$100.22M+26.1%

Similar metrics at other companies

Intrepid Potash logo
IPIMineral — Sales
$0+100%
Intrepid Potash logo
IPIOther — Sales
$28K-77.0%
Intrepid Potash logo
IPIPotash — Sales
$25.22M-9.1%
Intrepid Potash logo
IPISalt — Sales
$2.19M-31.4%
Intrepid Potash logo
IPITrio — Sales
$35.7M+7.5%
Intrepid Potash logo
IPIWater — Sales
$332K+24.8%

Other financials

Income statement

See full
Revenue$421.3M+2.7%
Gross profit$31.1M-47.0%
Net income$3.2M-89.6%
EPS (diluted)$0.12-89.6%

Balance sheet

See full
Cash & equivalents$7.2M-60.9%
Total debt$148.9M+8.1%
Total equity$796.9M-3.3%
Total assets$1.7B+1.6%

Cash flow

See full
Operating cash flow-$15.3M-234%
CapEx$20.7M-26.7%
Free cash flow-$10.7M-49.2%

Valuation

See full
Market cap$444.28M-9.5%
Enterprise value$586.01M-4.0%
P/S0.3×0.0×

Profitability

See full
Gross margin5.6%-6.3pp
Net margin-1%-6.1pp
FCF margin-1.7%

Returns & leverage

See full
Return on equity-1.8%-11.7pp
Debt / equity0.2×0.0×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by AdvanSix in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: AdvanSix’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001673985-26-000049
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Sales$421,284$410,022$825,468$787,813
Costs, expenses and other:
Cost of goods sold390,183351,308790,565675,628
Selling, general and administrative expenses22,05425,41644,57248,825
Interest expense, net2,6082,2555,0383,796
Other non-operating income, net(215)(607)(684)(1,015)
Total costs, expenses and other414,630378,372839,491727,234
Income (loss) before taxes6,65431,650(14,023)60,579

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is AdvanSix's caprolactam — sales?
AdvanSix (ASIX) reported caprolactam — sales of $62.64M in Q2 2026.
How has AdvanSix's caprolactam — sales changed year-over-year?
AdvanSix's caprolactam — sales decreased by 5.7% year-over-year, from $66.42M to $62.64M.
What is the long-term trend for AdvanSix's caprolactam — sales?
Over 4 years (2021 to 2025), AdvanSix's caprolactam — sales has grown at a -3.7% compound annual growth rate (CAGR), from $316.13M to $271.37M.
What does caprolactam — sales mean?
Represents the total gross revenue generated from the sale of caprolactam products within a specific reporting period. This metric reflects the market demand and pricing power for this chemical intermediate used in the production of Nylon 6 resins and fibers.

Ask your AI about AdvanSix's caprolactam — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude